Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Diabetes Mellitus, Type 1"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 37186
Tytuł:
A case of drug-induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction.
Autorzy:
Kobayashi Y; Department of Dermatology, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan.
Adachi T; Department of Dermatology, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan.; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.; Department of Medical Regulatory Science, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Arakawa H; Department of Dermatology, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan.
Minakata Y; Division of Cardiology, Department of Internal Medicine, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan.
Yajima K; Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan.
Inazumi T; Department of Dermatology, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan.
Pokaż więcej
Źródło:
The Journal of dermatology [J Dermatol] 2023 Dec; Vol. 50 (12), pp. 1603-1607. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Drug Hypersensitivity Syndrome*/complications
Drug Hypersensitivity Syndrome*/diagnosis
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/chemically induced
Eosinophilia*/drug therapy
Myocardial Infarction*
Diabetes Mellitus, Type 2*/complications
Male ; Humans ; Aged ; Carbamazepine/adverse effects ; Adrenal Cortex Hormones/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes: a cross-sectional, multicenter survey.
Autorzy:
Hepprich M; Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel and University of Basel, Basel, Switzerland .; Metabolic Center, Cantonal Hospital Olten, Olten, Switzerland.
Roser P; Department of Endocrinology and Diabetology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stiebitz S; Vitasphère Gesundheitszentrum Oensingen, Oensingen, Switzerland.
Felix B; Division of Endocrinology, Department of Internal Medicine, Cantonal Hospital Basel-Landschaft Campus Bruderholz, Binningen, Switzerland.
Schultes B; Metabolic Center St Gallen, friendlyDocs, St Gallen, Switzerland.
Schmitz D; Endocrinology, Hospital Rheinfelden, Rheinfelden, Switzerland.
Rutishauser J; MedCenter Volta Basel, Basel, Switzerland.
Schubert S; Diabetespraxis Buxtehude, Buxtehude, Germany.
Aberle J; Department of Endocrinology and Diabetology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rudofsky G; Praxis für Endokrinologie, Diabetes und Adipositas, Olten, Switzerland.
Pokaż więcej
Źródło:
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2023 Nov; Vol. 11 (6).
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/diagnosis
Diabetic Ketoacidosis*/epidemiology
Diabetic Ketoacidosis*/therapy
Humans ; Female ; Middle Aged ; Male ; Cross-Sectional Studies ; Ketones ; Ambulatory Care Facilities
Czasopismo naukowe
Szczegóły
Tytuł:
Responses to the Strengths and Difficulties Questionnaire predict HbA1c trajectories in children and adolescents with type 1 diabetes: a population-based study.
Autorzy:
Marks KP; Department of Clinical Medicine - Paediatrics, Aarhus Universitet, Aarhus, Denmark .; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
Pouwer F; Department of Psychology, University of Southern Denmark, Odense, Denmark.; Steno Diabetes Center Odense, Odense, Denmark.; Department of Medical Psychology, Amsterdam UMC, Amsterdam, The Netherlands.
Jensen MB; Department of Economics, Aarhus University, Aarhus, Denmark.
Ibfelt EH; Danish Clinical Quality Program-National Clinical Registries (RKKP), Frederiksberg, Denmark.; Steno Diabetes Center Copenhagen, The Capital Region, Denmark.
Kristensen LJ; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
Thastum M; Department of Psychology, Centre for Psychological Treatment of Children and Adolescents, Aarhus University, Aarhus, Denmark.
Birkebæk NH; Department of Clinical Medicine - Paediatrics, Aarhus Universitet, Aarhus, Denmark.; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.; Department of Paediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
Pokaż więcej
Źródło:
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2023 Nov; Vol. 11 (6).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 1*/psychology
Mental Disorders*
Female ; Humans ; Child ; Adolescent ; Male ; Glycated Hemoglobin ; Surveys and Questionnaires ; Psychometrics
Czasopismo naukowe
Szczegóły
Tytuł:
Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes.
Autorzy:
Lan NSR; Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Australia; Department of Cardiology, Fiona Stanley Hospital, Australia; Medical School, University of Western Australia, Australia. Electronic address: .
Hong RSY; Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Australia.
Ryan C; Department of Medicine, University of Melbourne, Australia.
Jenkins AJ; Baker Heart and Diabetes Institute, Melbourne, Australia.
Fegan PG; Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Australia; Medical School, Curtin University, Australia.
Pokaż więcej
Źródło:
Primary care diabetes [Prim Care Diabetes] 2023 Oct; Vol. 17 (5), pp. 526-528. Date of Electronic Publication: 2023 Jul 31.
Typ publikacji:
Journal Article
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects
Diabetes Mellitus, Type 1*/diagnosis
Diabetes Mellitus, Type 1*/drug therapy
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Dyslipidemias*/diagnosis
Dyslipidemias*/drug therapy
Humans ; Risk Factors ; Heart Disease Risk Factors ; Lipids
Czasopismo naukowe
Szczegóły
Tytuł:
Pancreas patch grafting to treat type 1 diabetes.
Autorzy:
Yi X; Department of Surgery, University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: .
Xie Y; Department of Surgery, University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: .
Gerber DA; Department of Surgery, University of North Carolina, Chapel Hill, NC, 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: david_.
Pokaż więcej
Źródło:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2023 Dec 17; Vol. 686, pp. 149200. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/therapy
Diabetes Mellitus, Type 1*/metabolism
Diabetes Mellitus, Experimental*/metabolism
Insulin-Secreting Cells*/metabolism
Humans ; Mice ; Animals ; Pancreas/metabolism ; Insulin/metabolism ; Cell Differentiation
Czasopismo naukowe
Szczegóły
Tytuł:
Adoptive transfer of immature dendritic cells with high HO-1 expression delays the onset of T1DM in NOD mice.
Autorzy:
Yang X; Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, People's Republic of China.
Ma Z; Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, People's Republic of China.
Tan X; Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China; Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, People's Republic of China.
Shi Y; Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, People's Republic of China.
Yuan M; Department of Nail and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, People's Republic of China.
Chen G; Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China; Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, People's Republic of China.
Luo X; Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, People's Republic of China. Electronic address: .
Hou L; Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2023 Dec 15; Vol. 335, pp. 122273. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/prevention & control
Diabetes Mellitus, Type 1*/metabolism
Animals ; Mice ; Adoptive Transfer ; Cells, Cultured ; Dendritic Cells ; Heme Oxygenase-1/metabolism ; Mice, Inbred NOD
Czasopismo naukowe
Szczegóły
Tytuł:
Research design and baseline participant characteristics of the Resilient, Empowered, Active Living with Diabetes - Telehealth (REAL-T) Study: A randomized controlled trial for young adults with type 1 diabetes.
Autorzy:
Pyatak EA; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America. Electronic address: .
Ali A; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Khurana AR; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Lee PJ; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Sideris J; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Fox S; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, United States of America.
Diaz J; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Granados G; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Blanchard J; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
McGuire R; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Salazar Plascencia E; Alpha Clinic, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Salcedo-Rodriguez E; Children's Hospital Los Angeles, Los Angeles, CA, United States of America.
Flores-Garcia J; Children's Hospital Los Angeles, Los Angeles, CA, United States of America.
Linderman M; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Taylor EE; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Tapia V; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Nnoli N; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America.
Sequeira PA; Department of Endocrinology, Los Angeles General Medical Center, Los Angeles, CA, United States of America.
Freeby MJ; David Geffen UCLA School of Medicine, Los Angeles, CA, United States of America.
Raymond JK; Alpha Clinic, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Pokaż więcej
Źródło:
Contemporary clinical trials [Contemp Clin Trials] 2023 Dec; Vol. 135, pp. 107386. Date of Electronic Publication: 2023 Nov 04.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 1*/therapy
Telemedicine*
Humans ; Young Adult ; Quality of Life ; Pandemics ; Research Design ; Blood Glucose/analysis
Czasopismo naukowe
Szczegóły
Tytuł:
Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial.
Autorzy:
Elbarbary NS; Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: nancy_.
Ismail EAR; Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Mohamed SA; Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Pokaż więcej
Źródło:
Clinical nutrition (Edinburgh, Scotland) [Clin Nutr] 2023 Dec; Vol. 42 (12), pp. 2372-2380. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Atherosclerosis*/complications
Atherosclerosis*/drug therapy
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/drug therapy
Diabetic Nephropathies*/drug therapy
Fatty Acids, Omega-3*/therapeutic use
Adolescent ; Humans ; Carotid Intima-Media Thickness ; Cholesterol, LDL ; Dietary Supplements ; Glycated Hemoglobin
Czasopismo naukowe
Szczegóły
Tytuł:
Fibroblast growth factor 21 protects the liver from apoptosis in a type 1 diabetes mouse model via regulating L-lactate homeostasis.
Autorzy:
Yan J; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Xie J; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Xu S; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Guo Y; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Ji K; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Li C; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Gao H; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou 325035, Zhejiang, China. Electronic address: .
Zhao L; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Dec; Vol. 168, pp. 115737. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 1*/metabolism
Mice ; Male ; Animals ; AMP-Activated Protein Kinases/metabolism ; Mice, Inbred C57BL ; Liver ; Fibroblast Growth Factors/pharmacology ; Fibroblast Growth Factors/metabolism ; Disease Models, Animal ; Glucose/metabolism ; Homeostasis ; Apoptosis ; Mice, Knockout
Czasopismo naukowe
Szczegóły
Tytuł:
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors.
Autorzy:
Sanz-Gómez M; Instituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Spain.
Manzano-Lista FJ; Instituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Spain.
Vega-Martín E; Instituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Spain.
González-Moreno D; Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad CEU-San Pablo, CEU Universities, 28925 Madrid, Spain.
Alcalá M; Departamento de Química y Bioquímica, Facultad de Farmacia, Universidad CEU-San Pablo, CEU Universities, 28925 Madrid, Spain.
Gil-Ortega M; Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad CEU-San Pablo, CEU Universities, 28925 Madrid, Spain.
Somoza B; Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad CEU-San Pablo, CEU Universities, 28925 Madrid, Spain.
Pizzamiglio C; Instituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Spain.
Ruilope LM; Unidad de Hipertensión, Instituto de Investigación Imas12, Hospital Universitario 12 de Octubre, Madrid, Spain.
Aránguez I; Instituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Spain.
Kolkhof P; Cardiovascular Precision Medicines, Research & Early Development, Pharmaceuticals, Bayer AG, Wuppertal, Germany.
Kreutz R; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Clinical Pharmacology and Toxicology, Germany. Electronic address: .
Fernández-Alfonso MS; Instituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Dec; Vol. 168, pp. 115661. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Renal Insufficiency, Chronic*
Humans ; Rats ; Animals ; Pulse Wave Analysis ; Rats, Wistar ; Kidney
Czasopismo naukowe
Szczegóły
Tytuł:
Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study.
Autorzy:
Makino H; Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.
Kanasaki K; Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2023 Dec; Vol. 14 (12), pp. 1341-1343. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetic Nephropathies*/genetics
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/genetics
Diabetic Retinopathy*/genetics
Humans ; Epigenesis, Genetic ; Disease Progression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Younger patients and low c-peptide immunoreactivity index but not nutritional states affect fasting blood ketone levels in Japanese with type 1 diabetes after sodium-glucose cotransporter 2 inhibitor administration.
Autorzy:
Nakajima H; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Okada H; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Yoshimura Y; Department of Endocrinology, Metabolism, and Diabetes, Saiseikai Suita Hospital, Osaka, Japan.
Tanaka T; Department of Diabetes and Endocrinology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Hasegawa G; Division of Metabolism and Rheumatology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
Mitsuhashi K; Department of Diabetes Internal Medicine, Fukuchiyama City Hospital, Kyoto, Japan.
Kitagawa N; Department of Diabetology, Kameoka Municipal Hospital, Kyoto, Japan.
Okamura T; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Hashimoto Y; Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, Moriguchi, Japan.
Senmaru T; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Ushigome E; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Nakanishi N; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Yamazaki M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Hamaguchi M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Fukui M; Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Dec; Vol. 25 (12), pp. 3682-3689. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/drug therapy
Ketosis*/chemically induced
Ketosis*/prevention & control
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Humans ; C-Peptide ; East Asian People ; Fasting ; Ketones
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical and biochemical determinants of length of stay, readmission and recurrence in patients admitted with diabetic ketoacidosis.
Autorzy:
Ata F; Department of Endocrinology, Hamad Medical Corporation, Doha, Qatar.
Khan AA; Department of Endocrinology, Hamad Medical Corporation, Doha, Qatar.
Khamees I; Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Iqbal P; Department of Medicine, New York Medical College/Metropolitan Hospital Center, New York, NY, USA.
Yousaf Z; Department of Medicine, Reading Hospital-Tower Health, West Reading, PA, USA.
Mohammed BZM; Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Aboshdid R; Department of Geriatrics, Hamad Medical Corporation, Doha, Qatar.
Marzouk SKK; College of Medicine, Qatar University, Doha, Qatar.
Barjas H; Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Khalid M; Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
El Madhoun I; Department of Nephrology, Hamad Medical Corporation, Doha, Qatar.
Bashir M; Department of Endocrinology, Hamad Medical Corporation, Doha, Qatar.
Kartha A; Department of Medicine, Hamad Medical Corporation, Doha, Qatar.; College of Medicine, Weill Cornell Medicine, Doha, Qatar.
Pokaż więcej
Źródło:
Annals of medicine [Ann Med] 2023 Dec; Vol. 55 (1), pp. 533-542.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetic Ketoacidosis*/epidemiology
Diabetic Ketoacidosis*/therapy
Diabetic Ketoacidosis*/complications
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 1*/therapy
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/therapy
Humans ; Male ; Female ; Adult ; Middle Aged ; Length of Stay ; Patient Readmission ; Retrospective Studies ; Cross-Sectional Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in type 1 diabetes and type 2 diabetes: Lipid goal attainment in a large German-Austrian diabetes registry.
Autorzy:
Brandts J; Department of Medicine I, University Hospital Aachen, Aachen, Germany.; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK.
Tittel SR; Institute for Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.; German Center for Diabetes Research (DZD), Munich, Germany.
Bramlage P; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.
Danne T; Kinderkrankenhaus auf der Bult, Diabeteszentrum für Kinder und Jugendliche, Hannover, Germany.
Brix JM; Department of Medicine I, Vienna, Austria.; Karl Landsteiner Institute for obesity and metabolism, Vienna, Austria.
Zimny S; Department of General Internal Medicine, Endocrinology and Diabetes, HELIOS Clinic Schwerin, Schwerin, Germany.
Heyer CHJ; Diabetespraxis Viersen, Viersen, Germany.
Holl RW; Institute for Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.; German Center for Diabetes Research (DZD), Munich, Germany.
Müller-Wieland D; Department of Medicine I, University Hospital Aachen, Aachen, Germany.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Dec; Vol. 25 (12), pp. 3700-3708. Date of Electronic Publication: 2023 Sep 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Atherosclerosis*
Anticholesteremic Agents*/therapeutic use
Dyslipidemias*/therapy
Adult ; Humans ; Aged ; Cholesterol, LDL ; Proprotein Convertase 9 ; Austria/epidemiology ; Goals ; Cholesterol ; Ezetimibe/therapeutic use ; Registries ; Fibric Acids
Czasopismo naukowe
Szczegóły
Tytuł:
Exploring the Causality of Type 1 Diabetes and Stroke Risk: A Mendelian Randomization Study and Meta-analysis.
Autorzy:
Zou X; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China. .
Zhang L; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P.R. China. .; Multi-Modal Monitoring Technology for Severe Cerebrovascular Disease of Human Engineering Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P.R. China. .
Wang L; Department of Pharmacy, Wuhan First Hospital, Wuhan, China.
Wang S; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China.
Zeng Y; Department of Geriatrics, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, P.R. China.
Pokaż więcej
Źródło:
Molecular neurobiology [Mol Neurobiol] 2023 Dec; Vol. 60 (12), pp. 6814-6825. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/genetics
Diabetes Mellitus, Type 2*
Stroke*/genetics
Humans ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Cerebral Hemorrhage/complications ; Cerebral Hemorrhage/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
Ofatumumab for the treatment of refractory anti-LGI1 encephalitis with long-term poor blood glucose control in type 1 diabetes.
Autorzy:
Chen K; Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Yang L; Department of Endocrinology, Jilin Province People's Hospital, Changchun, China.
Xu L; Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Jiang Y; Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
He J; Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Dec; Vol. 29 (12), pp. 4172-4174. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Letter
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/drug therapy
Encephalitis*
Humans ; Glycemic Control ; Proteins ; Autoantibodies
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Severe (level 3) hypoglycaemia occurrence in a real-world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States).
Autorzy:
Ratzki-Leewing A; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.; Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Black JE; Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Kahkoska AR; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Ryan BL; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.; Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Zou G; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.; Robarts Research Institute, Western University, London, Ontario, Canada.
Klar N; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Timcevska K; Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Harris SB; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.; Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.; Department of Medicine/Division of Endocrinology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Dec; Vol. 25 (12), pp. 3736-3747. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Hypoglycemia*/chemically induced
Hypoglycemia*/epidemiology
Hypoglycemia*/therapy
Humans ; Adult ; Male ; United States/epidemiology ; Middle Aged ; Hypoglycemic Agents/adverse effects ; Prospective Studies ; Secretagogues ; Insulin/adverse effects ; Insulin, Regular, Human
SCR Disease Name:
Diabetes Mellitus, Insulin-Dependent, 2
Czasopismo naukowe
Szczegóły
Tytuł:
Plasma leucine-rich α-2-glycoprotein 1 - a novel marker of diabetic kidney disease in children and adolescents with type 1 diabetes mellitus?
Autorzy:
Altıncık SA; Department of Pediatric Endocrinology, Pamukkale University, Denizli, Turkey.
Yıldırımçakar D; Department of Pediatric Endocrinology, Pamukkale University, Denizli, Turkey. .
Avcı E; Department of Medical Biochemistry, Pamukkale University, Denizli, Turkey.
Özhan B; Department of Pediatric Endocrinology, Pamukkale University, Denizli, Turkey.
Girişgen İ; Department of Pediatric Nephrology, Pamukkale University, Denizli, Turkey.
Yüksel S; Department of Pediatric Nephrology and Pediatric Rheumatology, Pamukkale University, Denizli, Turkey.
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Dec; Vol. 38 (12), pp. 4043-4049. Date of Electronic Publication: 2023 Jul 04.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/etiology
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/diagnosis
Humans ; Adolescent ; Child ; Cystatin C ; Leucine ; Albuminuria/diagnosis ; Albuminuria/etiology ; Glomerular Filtration Rate ; Glycoproteins/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Oral delivery of bi-autoantigens by bacterium-like particles (BLPs) against autoimmune diabetes in NOD mice.
Autorzy:
Mao R; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Wang J; Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing211200, China.
Xu Y; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Wang Y; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Wu M; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Mao L; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Chen Y; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Li D; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Zhang T; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Diao E; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection, School of Life Sciences, Huaiyin Normal University, Huai'an223300, China.
Chi Z; Huai'an First People's Hospital, Nanjing Medical University, Huai'an223300, China.
Wang Y; State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan430072, China.
Chang X; Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing211200, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2023 Dec; Vol. 30 (1), pp. 2173339.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 1*/prevention & control
Vaccines*
Animals ; Mice ; Mice, Inbred NOD ; Autoantigens ; Vaccines, Combined
Czasopismo naukowe
Szczegóły
Tytuł:
N-acetylcysteine combined with insulin attenuates myocardial injury in canines with type 1 diabetes mellitus by modulating TNF-α-mediated apoptotic pathways and affecting linear ubiquitination.
Autorzy:
Huang J; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Pang X; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Zhang X; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Qiu W; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Zhang X; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Wang R; Department of Animal Science, Henry Fok School of Biology and Agriculture, Shaoguan University, Shaoguan, Guangdong, China.
Xie W; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Bai Y; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Zhou S; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Liao J; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Xiong Z; Department of Cardiovascular Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Tang Z; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Su R; Department of Veterinary Internal Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China. Electronic address: .
Pokaż więcej
Źródło:
Translational research : the journal of laboratory and clinical medicine [Transl Res] 2023 Dec; Vol. 262, pp. 1-11. Date of Electronic Publication: 2023 Jul 07.
Typ publikacji:
Journal Article
MeSH Terms:
NF-kappa B*/metabolism
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/drug therapy
Humans ; Animals ; Dogs ; Tumor Necrosis Factor-alpha ; Insulin/metabolism ; Acetylcysteine/pharmacology ; Acetylcysteine/therapeutic use ; Apoptosis ; Ubiquitination
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 37186

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies